Trial intelligence / Profile preview

Telmisartan vs Candesartan in Healthy Volunteers

NCT02261116Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Apr 2002
Primary completion
Aug 2002
Modality
Small Molecules
01

Overview

A Phase 4 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Apr 2002; status: completed.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02261116.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02261116.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call